Which shoulder surgery works best for seniors with arthritis? a Head-to-Head trial
NCT ID NCT05395819
First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time
Summary
This study compares two types of shoulder replacement surgery—Total Shoulder Arthroplasty (TSA) and Reverse Total Shoulder Arthroplasty (RTSA)—in people aged 65 and older with advanced shoulder osteoarthritis. Participants are randomly assigned to one of the two procedures. The goal is to see which surgery leads to better shoulder function, quality of life, and fewer complications within the first year after surgery. This pilot study will also help determine if a larger trial is feasible.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Reverse Total Shoulder Arthroplasty (RTSA) and Total Shoulder Arthroplasty (TSA) surgical procedures
- What this could lead to
- If one procedure proves clearly better, surgeons may have clearer guidance on which shoulder replacement to use for older patients with osteoarthritis, potentially improving outcomes and reducing complications.
- What could go wrong
- This is a small pilot study with only 40 participants, so results may not apply to everyone. The trial is early-stage and designed mainly to test feasibility, not to provide definitive answers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2022
- Expected to finish
-
May 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
65 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patients who have failed standard non-surgical management of their shoulder osteoarthritis who would benefit from a shoulder arthroplasty. Failed medical management will be defined as persistent pain and disability despite adequate standard non-operative management for 6 months. Medical management will be defined as: 1. The use of drugs including analgesics and non-steroidal anti-inflammatory drugs 2. Physiotherapy consisting of stretching, strengthening and local modalities (ultrasound, cryotherapy, etc.) 3. Activity modification 2. Imaging, and intra-operative findings confirming advanced gleno-humeral cartilage loss 3. Patients may present with a glenoid deficiency and \>15 degrees of retroversion 4. 65 years of age and older Exclusion Criteria: 1. Active joint or systemic infection 2. Rotator cuff arthropathy 3. Need for an augmented glenoid component or a bone graft to correct version to within 10 degrees of neutral 4. Retroversion cannot be surgically corrected to within 10 degrees of neutral with a "high- side" ream technique 5. Significant muscle paralysis 6. Charcot's arthropathy 7. Major medical illness (life expectancy less than 1 year or unacceptably high operative risk) 8. Active Workers Compensation Board (WCB) claim 9. Unable to understand the consent form/process 10. Psychiatric illness that precludes informed consent 11. Unwilling to be followed for the duration of the study 12. History of previous shoulder surgery on affected side
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Shoulder osteoarthritis are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Collaborative Orthopaedic Research (CORe), Clinical Sciences Building
Edmonton, Alberta, T6G 2B7, Canada
-
Glen Sather Sports Medicine Clinic (University of Alberta)
Edmonton, Alberta, T6G 1Z1, Canada
-
Grey Nuns Community Hospital
Edmonton, Alberta, T6L 5X8, Canada
-
Kaye Edmonton Clinic
Edmonton, Alberta, T6G 1Z1, Canada
-
Royal Alexandra Hospital (Orthopaedic Surgical Centre)
Edmonton, Alberta, T5H 3V9, Canada
-
Sturgeon Community Hospital
St. Albert, Alberta, T8N 6C4, Canada
-
University of Alberta Hospital
Edmonton, Alberta, T6G 2B7, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Insulin gel and ultrasound: a new combo to fight joint inflammation?
- A Pocket-Sized coach for shoulder surgery recovery?
- Portable ultrasound could replace CT scans for shoulder assessment
- Faster shoulder rehab after surgery: does starting day one help?
- Could a short steroid course after surgery reduce pain and nausea?
- Could CBD be the next painkiller for shoulder surgery patients?